INDIO — Today, Assemblyman Jeff Gonzalez (R-Indio) announced the introduction of AB 641, which would create a public awareness program to address the stigma surrounding drug-induced movement disorders caused by antipsychotic medications — conditions that can be pervasive, debilitating, and irreversible.
“Drug-induced movement disorders, such as Tardive Dyskinesia (TD), affect many Californians who rely on antipsychotic medications to managemental health conditions. With an estimated 600,000 Americans living with TD, 65% remain unaware of their condition, which can significantly impair their quality of life,” said Assemblyman Gonzalez. “TD disproportionately impacts disenfranchised communities, including unhoused populations and veterans, who face compounded barriers to care. AB 641 aims to address this by establishing a public awareness program to combat the stigma surrounding drug-induced movement disorders. The bill will promote early detection, diagnosis, and treatment, while expanding access to vital healthcare services for those who need it most.”
